DRUG DISCOV TODAY 润色咨询

DRUG DISCOVERY TODAY

出版年份:1996 年文章数:2767 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2017-07-16 13805560183

    赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2013-07-17 匿名用户

    2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2012-01-05 匿名用户

    中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2011-12-22 ms1700929302443684

    if=6.422(2009)
    在药学领域算很高了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2011-07-15 匿名用户

    中过2006年

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2011-07-06 匿名用户

    06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2011-01-06 匿名用户

    不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=544300, encodeId=6e7a54430093, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497939, encodeId=3d7549e93968, content=2011年中过一次,总的来说需要好的研究方向。我不是约稿,给主编发建议后给的邀请。审稿时间总共3个月,6名审稿人,前后历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 17 10:45:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486191, encodeId=3a3e48619107, content=中过一篇,不容易的,说比较容易发是瞎扯。一定要有好的题目和全面深入的综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 05 21:16:00 CST 2012, time=2012-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817486, encodeId=d79f81e4867c, content=if=6.422(2009)<br> 在药学领域算很高了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Dec 22 19:30:00 CST 2011, time=2011-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483485, encodeId=60c148348505, content=中过2006年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jul 15 17:34:00 CST 2011, time=2011-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483341, encodeId=425948334177, content=06年投过1篇,给主编一个建议后给的邀请,审稿1月,minor revision,返修1周,就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 06 20:55:00 CST 2011, time=2011-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473232, encodeId=6d264e32320c, content=不容易发吧,毕竟6分以上的杂志。该杂志多是约稿,自由投一定要有一个好的建议,并得到Editor的授权后才可投送全文。我们去年投的一篇文章,经过五个Reviewers的评审,最后经过一次大修,目前还在小修阶段。这种药界的顶尖杂志,真的不好发的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 06 11:33:00 CST 2011, time=2011-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470256, encodeId=8dbe4e025608, content=比较容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Feb 20 22:48:00 CST 2010, time=2010-02-20, status=1, ipAttribution=)]
    2010-02-20 匿名用户

    比较容易发

    0

共21条页码: 2/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分